Canopy Growth (NASDAQ:CGC) Stock Price Down 3.8% – Here’s What Happened

Canopy Growth Corporation (NASDAQ:CGC)’s share price traded down 3.8% during mid-day trading on Friday . The stock traded as low as $1.63 and last traded at $1.6250. 13,981,633 shares were traded during trading, a decline of 18% from the average session volume of 17,032,730 shares. The stock had previously closed at $1.69.

Trending Headlines about Canopy Growth

Here are the key news stories impacting Canopy Growth this week:

• Positive Sentiment: Federal rescheduling boost — President Trump signed an executive order directing marijuana be moved toward Schedule III, which investors view as reducing regulatory and banking hurdles, opening research, and improving tax and financial access for cannabis companies. This is a clear sector catalyst that lifted sentiment. CNBC: Trump signs executive order reclassifying pot
• Positive Sentiment: Potential commercial upside — analysts and sector commentary point to easier CBD access, expanded research, and potential tax/banking relief (e.g., removing some effects of 280E), which could materially expand addressable markets and margins over time. Zacks: Trump Orders Marijuana Reclassification
• Neutral Sentiment: Policy is directional but not instantaneous — the order directs agencies to act and could take months to change enforcement, regulations, and tax treatment; outcomes depend on rulemaking and DOJ/FDA timelines. Investors must wait for implementation details. Business Insider: Trump signs executive order easing federal restrictions
• Neutral Sentiment: Analyst conviction underpins upside but adds volatility — firms like Roth MKM reiterated buy ratings and bullish targets, which helped fuel the pre‑market/early rally and higher trading volumes. That creates both buying interest and short‑term swing risk. Roth MKM Sticks to Their Buy Rating for Canopy Growth
• Negative Sentiment: Profit‑taking and rotation trimmed gains — after substantial pre-news appreciation (analyst optimism and earlier rallies), traders sold into strength; one outlet reports a sharp intraday pullback for Canopy. That selling pressure pushed CGC lower by the close. MoneyMorning: President Trump Signs Cannabis Executive Order: Canopy Growth Collapses
• Negative Sentiment: Company fundamentals and market structure risks — Canopy is still emerging from prior operating losses, has volatile revenue dynamics versus U.S. MSOs that may capture the biggest near‑term gains, and could take longer to benefit from U.S. policy changes, keeping investors cautious. AAII: Why Canopy Growth Stock Is Up

Analyst Ratings Changes

A number of research firms recently weighed in on CGC. Alliance Global Partners reissued a “neutral” rating on shares of Canopy Growth in a research report on Monday, December 15th. Wall Street Zen upgraded Canopy Growth from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Benchmark raised Canopy Growth from a “sell” rating to a “hold” rating in a research report on Monday, November 10th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Canopy Growth in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Reduce”.

Canopy Growth Stock Down 12.4%

The firm has a market capitalization of $545.32 million, a PE ratio of -0.76 and a beta of 0.40. The stock has a 50-day simple moving average of $1.27 and a 200-day simple moving average of $1.31. The company has a quick ratio of 4.23, a current ratio of 5.50 and a debt-to-equity ratio of 0.31.

Canopy Growth (NASDAQ:CGC) last posted its quarterly earnings results on Friday, November 7th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.10. Canopy Growth had a negative return on equity of 61.97% and a negative net margin of 113.21%.The company had revenue of $47.86 million during the quarter, compared to the consensus estimate of $71.82 million. Analysts forecast that Canopy Growth Corporation will post -2.81 EPS for the current year.

Insiders Place Their Bets

In other Canopy Growth news, CEO Luc Mongeau bought 27,469 shares of Canopy Growth stock in a transaction dated Monday, September 22nd. The stock was purchased at an average price of $1.82 per share, for a total transaction of $49,993.58. Following the completion of the purchase, the chief executive officer directly owned 812,368 shares of the company’s stock, valued at approximately $1,478,509.76. This trade represents a 3.50% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 23,075 shares of company stock worth $36,459 in the last three months. 0.16% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Tidal Investments LLC raised its holdings in Canopy Growth by 31.5% during the 2nd quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock valued at $6,141,000 after acquiring an additional 1,204,530 shares during the period. Millennium Management LLC raised its stake in shares of Canopy Growth by 196.9% during the 3rd quarter. Millennium Management LLC now owns 3,137,696 shares of the company’s stock valued at $4,579,000 after purchasing an additional 2,080,994 shares during the period. Two Sigma Investments LP purchased a new stake in Canopy Growth during the 3rd quarter worth about $1,767,000. Jones Financial Companies Lllp lifted its holdings in Canopy Growth by 10,308.3% during the 1st quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock worth $882,000 after purchasing an additional 960,218 shares in the last quarter. Finally, SBI Securities Co. Ltd. boosted its stake in Canopy Growth by 9.8% in the 3rd quarter. SBI Securities Co. Ltd. now owns 584,755 shares of the company’s stock worth $854,000 after purchasing an additional 52,214 shares during the period. 3.33% of the stock is owned by institutional investors.

About Canopy Growth

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.